SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+2.97%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.24B
AUM Growth
+$1.24B
(-6.3%)
Cap. Flow
-$27.3M
Cap. Flow
% of AUM
-2.21%
Top 10 Holdings %
Top 10 Hldgs %
21.29%
Holding
139
New
26
Increased
28
Reduced
58
Closed
12
Top Buys
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$24.3M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$23.4M |
| 3 |
Aveanna Healthcare
AVAH
|
$20.5M |
| 4 |
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
|
$19.9M |
| 5 |
AGTI
Agiliti, Inc.
AGTI
|
$18.1M |
Top Sells
| 1 |
PPD
PPD, Inc. Common Stock
PPD
|
$32.3M |
| 2 |
Novavax
NVAX
|
$21.8M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$17.2M |
| 4 |
Arvinas
ARVN
|
$14.4M |
| 5 |
ACCD
Accolade, Inc. Common Stock
ACCD
|
$13.1M |
Sector Composition
| 1 | Healthcare | 94.02% |
| 2 | Industrials | 4.68% |
| 3 | Financials | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Tourmaline Bio
TRML
$645M
| $10.4M | 0.85% |
+711,000
| New | +$10.4M |
|
52
AbbVie
ABBV
$374B
| $10M | 0.81% |
89,000
-2,500
| -3% | -$282K |
|
53
Labcorp
LH
$22.8B
| $9.58M | 0.77% |
34,712
-44,100
| -56% | -$12.2M |
|
54
Medtronic
MDT
$118B
| $9.57M | 0.77% |
77,101
+24,600
| +47% | +$3.05M |
|
55
Cooper Companies
COO
$13.3B
| $9.54M | 0.77% |
24,080
-10,620
| -31% | -$4.21M |
|
56
Insulet
PODD
$24.2B
| $9.54M | 0.77% |
34,754
-12,600
| -27% | -$3.46M |
|
57
ESSA Pharma
EPIX
$11.2M
| $9.48M | 0.77% |
331,963
-40,000
| -11% | -$1.14M |
|
58
NovoCure
NVCR
$1.35B
| $9.27M | 0.75% |
+41,800
| New | +$9.27M |
|
59
Guardant Health
GH
$8.11B
| $8.97M | 0.73% |
72,186
+800
| +1% | +$99.4K |
|
|
CTLT
60
DELISTED
CATALENT, INC.
CTLT
| $8.89M | 0.72% |
82,250
+4,000
| +5% | +$432K |
|
61
Eli Lilly
LLY
$661B
| $8.5M | 0.69% |
37,015
-9,700
| -21% | -$2.23M |
|
62
Charles River Laboratories
CRL
$7.99B
| $8.43M | 0.68% |
+22,800
| New | +$8.43M |
|
63
Teladoc Health
TDOC
$1.37B
| $8.42M | 0.68% |
50,638
-74,075
| -59% | -$12.3M |
|
64
Bristol-Myers Squibb
BMY
$96.7B
| $8.39M | 0.68% |
125,574
| – | – |
|
|
HARP
65
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $8.06M | 0.65% |
580,759
-50,291
| -8% | -$698K |
|
66
Quanterix
QTRX
$202M
| $7.87M | 0.64% |
134,186
-109,503
| -45% | -$6.42M |
|
67
Molina Healthcare
MOH
$9.6B
| $7.77M | 0.63% |
30,697
-7,200
| -19% | -$1.82M |
|
68
Exelixis
EXEL
$9.95B
| $7.62M | 0.62% |
418,370
-71,688
| -15% | -$1.31M |
|
69
Pfizer
PFE
$141B
| $7.57M | 0.61% |
193,400
+106,000
| +121% | +$4.15M |
|
70
Vor Biopharma
VOR
$253M
| $7.56M | 0.61% |
405,324
-129,935
| -24% | -$2.42M |
|
71
Treace Medical Concepts
TMCI
$458M
| $7.53M | 0.61% |
+240,765
| New | +$7.53M |
|
72
Exact Sciences
EXAS
$9.33B
| $7.27M | 0.59% |
58,500
+3,500
| +6% | +$435K |
|
73
Dentsply Sirona
XRAY
$2.77B
| $6.83M | 0.55% |
+108,000
| New | +$6.83M |
|
74
Biogen
BIIB
$20.8B
| $6.73M | 0.54% |
19,432
+6,950
| +56% | +$2.41M |
|
75
STAAR Surgical
STAA
$1.35B
| $6.56M | 0.53% |
+43,000
| New | +$6.56M |
|